Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Henry Fernandez Insider Profile
11 Followers
Henry Fernandez, Chairman & CEO, Director at MSCI, holds 100.17K shares in Royalty Pharma (Ticker: RPRX), holds 2.11M shares in MSCI (Ticker: MSCI).
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-9.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Henry Fernandez holds in companies
Most Profitable Insider Trade
The most profitable trade made by Henry Fernandez
Henry Fernandez's Trading History
MSCI
Feb 07, 2024
Chairman & CEO, Director
Uninformative Buy
―
$1.07B
Royalty Pharma
Apr 02, 2024
Director
Uninformative Buy
37.47K
$2.79M
List of latest transactions for each holding click on a transaction to see Henry Fernandez's performance on stock
You May Also Like
Henry Fernandez insider profile FAQ
What is the percentage of profitable transactions made by Henry Fernandez?
The percentage of profitable transactions made by Henry Fernandez is 0%.
What is the average return per transaction made by Henry Fernandez?
The average return per transaction made by Henry Fernandez is -9.70%.
What stocks does Henry Fernandez hold?
Henry Fernandez holds: MSCI, RPRX stocks.
What was Henry Fernandez’s latest transaction?
Henry Fernandez latest transaction was an Uninformative Buy of $37.47K.
What was Henry Fernandez's most profitable transaction?
Henry Fernandez’s most profitable transaction was an Informative Buy of RPRX stock on February 25, 2022. The return on the trade was -3.60%.
What is Henry Fernandez's role in MSCI?
Henry Fernandez's role in MSCI is Chairman & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.